Our Taiwan patent on intravesical xenogeneic urothelail cell immunotherapy for bladder cancer has been issued!
相關文章
08
2 月
2024 New Breakthrogh~ US patent on xenogeneic urothelial cell therapy on bladder cancer has been issued
The United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,891,628 entitled...
08
7 月
2023 eXCELL Biotech Received a Japan Patent for the method to manufacture xenogeneic urothelial cells and the theraputic use of intravesical administration of xenogeneic urothelial cells to treat bladder cancer and cystitis.
The Japan Patent Office has granted a patent (Patent No. 7272676) for our intravesical xenogeneic ur...